FIRST MANHATTAN CO. LLC. - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 288 filers reported holding SEATTLE GENETICS INC in Q1 2018. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$665,000
+15.3%
3,4000.0%0.00%0.0%
Q2 2020$577,000
+47.2%
3,4000.0%0.00%0.0%
Q1 2020$392,000
+1.0%
3,4000.0%0.00%
+50.0%
Q4 2019$388,000
+33.8%
3,4000.0%0.00%0.0%
Q3 2019$290,000
+23.4%
3,4000.0%0.00%
+100.0%
Q2 2019$235,000
-5.6%
3,4000.0%0.00%0.0%
Q1 2019$249,000
+29.7%
3,4000.0%0.00%0.0%
Q4 2018$192,000
-26.7%
3,4000.0%0.00%0.0%
Q3 2018$262,000
+25.4%
3,400
+7.9%
0.00%0.0%
Q2 2018$209,000
+27.4%
3,1500.0%0.00%0.0%
Q1 2018$164,000
-2.4%
3,1500.0%0.00%0.0%
Q4 2017$168,000
-1.8%
3,1500.0%0.00%0.0%
Q3 2017$171,000
+5.6%
3,1500.0%0.00%0.0%
Q2 2017$162,000
+8.0%
3,150
+31.2%
0.00%0.0%
Q1 2017$150,000
+14.5%
2,400
-4.0%
0.00%0.0%
Q4 2016$131,000
-3.0%
2,5000.0%0.00%0.0%
Q3 2016$135,000
+33.7%
2,5000.0%0.00%0.0%
Q2 2016$101,000
+16.1%
2,5000.0%0.00%0.0%
Q1 2016$87,000
-22.3%
2,5000.0%0.00%0.0%
Q4 2015$112,000
+16.7%
2,5000.0%0.00%0.0%
Q3 2015$96,000
-20.7%
2,5000.0%0.00%0.0%
Q2 2015$121,000
+37.5%
2,5000.0%0.00%0.0%
Q1 2015$88,000
+25.7%
2,500
+13.6%
0.00%
Q4 2014$70,000
-13.6%
2,2000.0%0.00%
Q3 2014$81,000
-3.6%
2,2000.0%0.00%
-100.0%
Q2 2014$84,000
-7.7%
2,200
+10.0%
0.00%0.0%
Q1 2014$91,000
+15.2%
2,0000.0%0.00%0.0%
Q4 2013$79,000
-9.2%
2,0000.0%0.00%0.0%
Q3 2013$87,000
+10.1%
2,0000.0%0.00%0.0%
Q2 2013$79,0002,0000.00%
Other shareholders
SEATTLE GENETICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Baker Brothers Advisors 45,725,556$2,487,928,00020.18%
Lagoda Investment Management, L.P. 306,694$16,687,0006.03%
NEXTHERA CAPITAL LP 373,000$20,295,0005.22%
Redmile Group, LLC 1,843,733$100,318,0004.95%
Matrix Capital Management Company, LP 2,118,000$115,240,0003.68%
Sio Capital Management, LLC 100,000$5,441,0002.82%
Opus Point Partners Management, LLC 41,263$2,245,0002.01%
Eventide Asset Management 525,000$28,565,0001.62%
EMORY UNIVERSITY 35,982$1,958,0001.55%
Everett Capital Advisors UK LLP 191,500$10,420,0001.54%
View complete list of SEATTLE GENETICS INC shareholders